Author Details

Ametov, A. S

Issue Section Title File
No 16 (2012) Articles Nevropatiya i prediabet: eti chasy nachinayut tikat' rano
No 16 (2012) Articles Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
No 16 (2012) Articles Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
No 5 (2013) Articles SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
No 5 (2013) Articles INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
No 5 (2013) Articles SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
No 16 (2013) Articles Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
No 16 (2013) Articles Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
No 16 (2013) Articles Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
No 5 (2014) Articles VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
No 16 (2014) Articles Kompleksnoe lechenie erektil'noy disfunktsii u muzhchin s ozhireniem
No 5 (2015) Articles Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
No 10 (2015) Articles Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
No 5 (2016) Articles GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
No 5 (2017) Articles PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Vol 26, No 14 (2019) Articles Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies